Fig. 4

Immunological characteristics between low-risk score and high-risk score groups in the GSE9891 cohort. (A) DEG analysis between the high- and low- risk score groups. (B) Pathway enrichment analyses of genes up-regulated in the high- and low-risk score groups, respectively. (C) Comparing the StromalScore, ImmuneScore, ESTIMATEScore, and tumor purity between high- and low-risk score in the GSE9891 cohort. (D) Heatmap showing the expression levels of conventional biomarkers of immune subpopulations. (E) The correlation between risk score and the enrichment scores of immune subpopulations and immune-related signaling pathways in the GSE9891 cohort. (F) The correlation between risk score and the enrichment scores of anti-tumor cycles in the GSE9891 cohort